Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Cited by (1,021)

Items 901–1,000 of 1,021

  1. Antagonism of the 5-HT 6 receptor – Preclinical rationale for the treatment of Alzheimer's disease
    Inge E.M. de Jong, Arne Mørk · 2017 · Neuropharmacology
  2. Physostigmine for dementia due to Alzheimer's disease
    João M JMC Coelho Filho, Jacqueline Birks · 2001 · Cochrane Database of Systematic Reviews
  3. Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex
    George W. Huntley, Deanna L. Benson, Edward G. Jones, Paul J. Isackson · 1992 · Developmental Brain Research
  4. Synthesis and Biological Characterization of 1,4,5,6-Tetrahydropyrimidine and 2-Amino-3,4,5,6-tetrahydropyridine Derivatives as Selective m1 Agonists
    William S. Messer, Yahaya F. Abuh, Yang Liu, Sumudra Periyasamy, Dan O. Ngur, Michael A. N. Edgar, Afif A. El‐Assadi, Sbeih, Philip G. Dunbar, Scott Roknich et al. · 1997 · Journal of Medicinal Chemistry
  5. Decreased Cortical Glucose Utilization after Ibotenate Lesion of the Rat Ventromedial Globus Pallidus
    Edythe D. London, Michael McKinney, Mauro Dam, Albert Ellis, Joseph T. Coyle · 1984 · Journal of Cerebral Blood Flow & Metabolism
  6. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type
    D. Dawbarn, Martin N. Rossor, C.Q. Mountjoy, Martin Roth, Piers C. Emson · 1986 · Neuroscience Letters
  7. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor
    Vahram H. Haroutunian, Philip D. Kanof, Kenneth L. Davis · 1986 · Brain Research
  8. α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity
    Letsinger, Ayland C., Gu, Zhenglin, Yakel, Jerrel L. · 2022 · Trends in Neurosciences
  9. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice
    Krzywkowski, P., Ghribi, O., Gagné, J., Chabot, C., Kar, S., Rochford, J., Massicotte, G., Poirier, J. · 1999 · Neuroscience
  10. The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms
    Hang Guo, Min Liu, Lixia Zhang, Long Wang, Wugang Hou, Yaqun Ma, Yulong Ma · 2020 · Current Neuropharmacology
  11. Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
    Chi Him Poon, Yingyi Wang, Man‐Lung Fung, Chengfei Zhang, Lee Wei Lim · 2020 · Aging and Disease
  12. Potential drug–drug interactions in Alzheimer patients with behavioral symptoms
    Fabio Monzani, Giuseppe Pasqualetti, Sara Tognini, Valeria Calsolaro, Antonio Polini · 2015 · Clinical Interventions in Aging
  13. The rat as an animal model of Alzheimer's disease
    Eiríkur Benedikz, Ewa Kloskowska, Bengt G. Winblad · 2009 · Journal of Cellular and Molecular Medicine
  14. Neurite outgrowth induced by spicatoside A, a steroidal saponin, via the tyrosine kinase A receptor pathway
    Jinyoung Hur, Pyeongjae Lee, Eunjung Moon, Insug Kang, Sung‐Hoon Kim, Myung Sook Oh, Sun Yeou Kim · 2009 · European Journal of Pharmacology
  15. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles
    Hans-Christian Fritz, Nicola J. Ray, Martin Dyrba, Christian Sorg, Stefan Johannes Teipel, Michel J. Grothe · 2018 · Human Brain Mapping
  16. Noradrenergic and cholinergic interactions in the amygdala and the modulation of memory storage
    Carla Dalmaz, Ines B. Introini-Collison, James Lafayette McGaugh · 1993 · Behavioural Brain Research
  17. Protective effect of donepezil against Aβ(1-40) neurotoxicity in rat septal neurons
    Manami Kimura, Shigeru Akasofu, Hiroo Ogura, Kohei Sawada · 2005 · Brain Research
  18. Characterization of perforant path lesions in rodent models of memory and attention
    D.L. Kirkby, Guy A. Higgins · 1998 · European Journal of Neuroscience
  19. Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques
    Thomas G Aigner, Susan J. Mitchell, John P. Aggleton, Mahlon R. DeLong, R. G. Struble, Donald L. Price, Gary L. Wenk, Karen D. Pettigrew, Mortimer Mishkin · 1991 · Experimental Brain Research
  20. Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: Measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity
    Paul A. Lapchak, Franz F. Hefti · 1991 · Neuroscience
  21. Visualization of cholinoceptive neurons in the rat neocortex: colocalization of muscarinic and nicotinic acetylcholine receptors
    Eddy A. van der Zee, Cerien Streefland, Arthur Donny Strosberg, Heinz Christoph Schröder, Paul G.M. Luiten · 1992 · Molecular Brain Research
  22. Aging Decreases the Sensitivity of Rat Cortical Synaptosomes to Calcium Ionophore‐Induced Acetylcholine Release
    E. M. Meyer, Fulton T. Crews, Deborah H. Otero, K. Larsen · 1986 · Journal of Neurochemistry
  23. The role of synaptic microRNAs in Alzheimer's disease
    Subodh Kumar, P. Hemachandra Reddy · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  24. A Review of the Current Mammalian Models of Alzheimer’s Disease and Challenges That Need to Be Overcome
    Natasha E. Mckean, Renée R. Handley, Russell G. Snell · 2021 · International Journal of Molecular Sciences
  25. New biologically potent benzimidazole‐based‐triazole derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors along with molecular docking study
    Yousaf Khan, Wajid Ur Rehman, Rafaqat Hussain, Shoaib Khan, Aneela Malik, Marwa Khan, Anjum Liaqat, Liaqat Rasheed, Faiza Begum, Srosh Fazil et al. · 2022 · Journal of Heterocyclic Chemistry
  26. Understanding the cause of sporadic Alzheimer’s disease
    Zetterberg, Henrik, Mattsson, Niklas · 2014 · Expert Review of Neurotherapeutics
  27. Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease
    R.G. Wiley, T.G. Berbos, T L Deckwerth · 1995 · Journal of the Neurological Sciences
  28. Chapter 26 Reduced neuronal activity and reactivation in Alzheimer's disease
    Dick Frans Swaab, Paul John Lucassen, Ahmad Salehi, Erik Scherder, Eus J.W. Van Someren, Ronald W. H. Verwer · 1998 · Progress in brain research
  29. Neurogenesis of the basal forebrain in euploid and trisomy 16 mice: An animal model for developmental disorders in down syndrome
    Joanne E. Sweeney, Christine F. Höhmann, Mary Lou Oster‐Granite, Joseph T. Coyle · 1989 · Neuroscience
  30. Preferential Cerebrospinal Fluid Acetylcholinesterase Inhibition by Rivastigmine in Humans
    John S. Kennedy, Ronald J. Polinsky, Benjamin W Johnson, Peter T. Loosen, Albert Enz, Robert Laplanche, Dennis E. Schmidt, Linda Mancione, Winston C. V. Parris, Michael H. Ebert · 1999 · Journal of Clinical Psychopharmacology
  31. An interaction between thyroid hormone and nerve growth factor in the regulation of choline acetyltransferase activity in neuronal cultures, derived from the septal-diagonal band region of the embryonic rat brain
    Masao Hayashi, Ambrish J. Patel · 1987 · Developmental Brain Research
  32. Impaired Modulation of GABAergic Transmission by Muscarinic Receptors in a Mouse Transgenic Model of Alzheimer's Disease
    Zhong, Ping, Gu, Zhenglin, Wang, Xun, Jiang, Houbo, Feng, Jian, Yan, Zhen · 2003 · Journal of Biological Chemistry
  33. Near-Infrared Fluorescence Probe for Evaluating Acetylcholinesterase Activity in PC12 Cells and In Situ Tracing AChE Distribution in Zebrafish
    Jianlong Ma, Tiantian Si, Chaoxian Yan · 2019 · ACS Sensors
  34. Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART
    Alexander J. Ehrenberg, Michael A. Kelberman, Kathy Y Liu, Martin J. Dahl, David Weinshenker, Neus Falgàs, Shubir Dutt, Mara Mather, Mareike Ludwig, Matthew J. Betts et al. · 2023 · Alzheimer s & Dementia
  35. Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease*
    Sanjay Asthana, Nigel H. Greig, Harold W. Holloway, Kathleen C. Raffaele, Annamaria Berardi, Mark B. Schapiro, Stanley Isaac Rapoport, Timothy T. Soncrant · 1996 · Clinical Pharmacology & Therapeutics
  36. Modulation of Nicotinic Receptor Activity in the Central Nervous System
    Edson Xavier Albuquerque, Máriton D. Santos, Manickavasagom Alkondon, Edna F. R. Pereira, Alfred Maelicke · 2001 · Alzheimer Disease & Associated Disorders
  37. Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease
    John J. Sramek, Ravi Anand, Thomas S. Wardle, Peter Irwin, Richard D. Hartman, Neal R. Cutler · 1996 · Life Sciences
  38. Regional spectral analysis of the REM sleep EEG in mild to moderate Alzheimer's disease
    Dominique Petit, Dominique Lorrain, Serge G. Gauthier · 1993 · Neurobiology of Aging
  39. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task
    James J. Chrobak, Israel Hanin, Thomas J. Walsh · 1987 · Brain Research
  40. Cholinergic receptors in aging and Alzheimer's disease
    Peter John Whitehouse, Kin Sing Au · 1986 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  41. Stability of neuronal number in the human nucleus basalis of Meynert with age
    Helena Chang Chui, William Bondareff, Chris Zarow, Ursula T. Slager · 1984 · Neurobiology of Aging
  42. Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum
    Erik Messamore · 1993 · Neuropharmacology
  43. Effects of Nucleus Basalis Lesions on the Muscarinic and Nicotinic Modulation of [3H] Acetylcholine Release in the Rat Cerebral Cortex
    Edwin M. Meyer, Gary W. Arendash, Jennifer H. Judkins · 1987 · Journal of Neurochemistry
  44. Intracerebral drug delivery in rats with lesion-induced memory deficits
    Matthew A. Howard, Alan Gross, Michael Sean Grady, Róbert Langer, Edith Mathiowitz, H. Richard Winn, Marc R. Mayberg · 1989 · Journal of neurosurgery
  45. In vivo functional evaluation of central cholinergic circuits in vascular dementia
    Vincenzo Di Lazzaro, Fabio Pilato, Michele Dileone, Paolo Profice, Camillo Marra, Federico Ranieri, Davide Quaranta, Guido Gainotti, Pietro Tonali · 2008 · Clinical Neurophysiology
  46. A novel mechanism of hippocampal LTD involving muscarinic receptor-triggered interactions between AMPARs, GRIP and liprin-α
    Bryony A Dickinson, Jihoon Jo, Heon Seok, Gi Hoon Son, Daniel J. Whitcomb, Ceri H. Davies, Morgan Sheng, Graham L. Collingridge, Kwangwook Cho · 2009 · Molecular Brain
  47. Cerebrospinal fluid levels of angiotensin- converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: A correlative study
    George S. Zubenko, Judith K. Marquis, Ladislav Volicer, Lome K. Direnfeld, Philip J. Langlais, Ralph A. Nixon · 1986 · Biological Psychiatry
  48. Galantamine: Therapeutic Effects beyond Cognition
    Rafael Blesa · 2000 · Dementia and Geriatric Cognitive Disorders
  49. Differential responsivity of mood, behavior and cognition to cholinergic agents in elderly neuropsychiatric populations
    Trey Sunderland, Pierre N. Tariot, PAUL A. NEWHOUSE · 1988 · Brain Research Reviews
  50. Antiamnesic Effects of Desmodium gangeticum in Mice
    JOSHI, Hanumanthachar, PARLE, Milind · 2006 · YAKUGAKU ZASSHI
  51. Alzheimer disease: Plaques, tangles, and the basal forebrain
    Peter John Whitehouse, Robert G. Struble, Arthur W. Clark, Donald L. Price · 1982 · Annals of Neurology
  52. Cholinergic imbalance in the multiple sclerosis hippocampus
    Evert‐Jan Kooi, Marloes Prins, Natasha Bajic, Jeroen A.M. Beliën, Wouter H. Gerritsen, Jack van Horssen, Eleonora Aronica, Anne‐Marie van Dam, Jeroen J.M. Hoozemans, Paul T. Francis et al. · 2011 · Acta Neuropathologica
  53. A comparison between the connections of the amygdala and hippocampus with the basal forebrain in the macaque
    John P. Aggleton, David P. Friedman, Mortimer Mishkin · 1987 · Experimental Brain Research
  54. Rivastigmine, a Brain-Selective Acetylcholinesterase Inhibitor, Ameliorates Cognitive and Motor Deficits Induced by Closed-Head Injury in the Mouse
    Yun Chen, Esther Shohami, Shlomi Constantini, Marta Weinstock · 1998 · Journal of Neurotrauma
  55. Distribution of the putative vesicular transporter for acetylcholine in the rat central nervous system
    Ali Roghani, A Shirzadi, Larry L. Butcher, Robert H. Edwards · 1997 · Neuroscience
  56. Rodent models of memory dysfunction in Alzheimer's disease and normal aging: Moving beyond the cholinergic hypothesis
    Donald K. Ingram, Edward L. Spangler, Setsu Iijima, Hiroyuki Ikari, Hui Kuo, Nigel H. Greig, Edythe D. London · 1994 · Life Sciences
  57. Normal pressure hydrocephalus. Influences on cerebral hemodynamic and cerebrospinal fluid pressure-chemical autoregulation
    John Stirling Meyer, Hisao Tachibana, Jeffrey P. Hardenberg · 1984 · Surgical Neurology
  58. Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable
    Martin F. Sarter · 1998 · Brain Research Reviews
  59. Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease.
    G. Ransmayr, P. Cervera, Étienne C. Hirsch, M. Ruberg, L. Hersh, C. Duyckaerts, J. Hauw, C. Delumeau, Y. Agid · 1989 · Neuroscience
  60. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.
    Ahmed A. Bajalan, C E Wright, V J van der Vliet · 1986 · Journal of Neurology Neurosurgery & Psychiatry
  61. A long-lasting cholinesterase inhibitor affecting neural and behavioral processes
    M. Brufani, Claudio Castellano, Maurizio Marta · 1987 · Pharmacology Biochemistry and Behavior
  62. Cellular pathology in Alzheimer's and Parkinson's diseases
    Donald L. Price, Peter John Whitehouse, Robert G. Struble · 1986 · Trends in Neurosciences
  63. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease
    Pentz, Rowan, Iulita, M. Florencia, Ducatenzeiler, Adriana, Bennett, David A., Cuello, A. Claudio · 2021 · Molecular Psychiatry
  64. The septo-hippocampal system, learning and recovery of function
    Niewiadomska, Grazyna, Baksalerska-Pazera, Marta, Riedel, Gernot · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  65. Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model
    Smit, Tamar, Deshayes, Natasja A. C., Borchelt, David R., Kamphuis, Willem, Middeldorp, Jinte, Hol, Elly M. · 2021 · Glia
  66. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biological evaluation
    Shoaib Manzoor, Santosh Kumar Prajapati, Shreyasi Majumdar, Md Kausar Raza, Moustafa Tarek Gabr, Shivani Kumar, Kavita Pal, Haroon Ur Rashid, Suresh Kumar, Sairam Krishnamurthy et al. · 2021 · European Journal of Medicinal Chemistry
  67. Neuroprotective effect of steroidal alkaloids on glutamate-induced toxicity by preserving mitochondrial membrane potential and reducing oxidative stress
    Marcos Taveira, Carla Sousa, Patrı́cia Valentão, Federico Ferreres, João Paulo Teixeira, Paula B. Andrade · 2013 · The Journal of Steroid Biochemistry and Molecular Biology
  68. An update on huperzine A as a treatment for Alzheimer's disease
    John T. Little, Sally P. Walsh, Paul S. S. Aisen · 2008 · Expert Opinion on Investigational Drugs
  69. Alzheimer disease constricts the dynamic range of spatial attention in visual search
    Raja Parasuraman · 2000 · Neuropsychologia
  70. Anatomy of rat semaphorin III collapsin‐1 mRNA expression and relationship to developing nerve tracts during neuroembryogenesis
    Roman J. Giger, David Paul Wolfer, Gerard M.J. de Wit, Joost Verhaagen · 1996 · The Journal of Comparative Neurology
  71. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics
    Nigel H. Greig, Enrico De Micheli, Harold W. Holloway, Quian-Sheng Yu, Tada Utsuki, TracyAnn Perry, D. K. Ingram, Joseph Deutsch, Debomoy K. Lahiri, Timothy T. Soncrant · 2000 · Acta Neurologica Scandinavica
  72. Neurophysiology of magnocellular forebrain inputs to the olfactory bulb in the rat: frequency potentiation of field potentials and inhibition of output neurons
    W.T. Nickell, MT Shipley · 1988 · Journal of Neuroscience
  73. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats
    Takashi Kosasa, Yuka Kuriya, Kenji Matsui, Yoshiharu Yamanishi · 1999 · European Journal of Pharmacology
  74. Age-impaired impulse flow from nucleus basalis to cortex
    Gary Aston‐Jones, Joseph Rogers, Robert D. Shaver, Timothy G. Dinan, Donald E. Moss · 1985 · Nature
  75. Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders
    Carthage J. Smith, Elaine King Perry, Robert Henry Perry · 1988 · Journal of Neurochemistry
  76. Structure‐function studies of nerve growth factor: functional importance of highly conserved amino acid residues.
    Carlos F. Ibáñez, Finn Hallböök, Ted Ebendal · 1990 · The EMBO Journal
  77. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia
    Yousuke Ichimiya, Piers C. Emson, C.Q. Mountjoy · 1989 · Brain Research
  78. Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze
    Edward D. Levin, Susan R. McGurk, D Avies South · 1989 · Behavioral and Neural Biology
  79. The role of inflammatory processes in Alzheimer’s disease
    Gerard Joey Broussard, Jennifer O. Mytar, Rung‐chi Li, Gloria J. Klapstein · 2012 · Inflammopharmacology
  80. Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease
    Gaurav Bedse, Adele Romano, Silvia Cianci, Angelo Michele Lavecchia, Lorenzo Pace, Maurice R. Elphick, Frank M. LaFerla, Gianluigi Vendemiale, Caterina Grillo, Fabio Altieri F. et al. · 2014 · Journal of Alzheimer s Disease
  81. MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation
    Nanako Hamada, Yasunori Fujita, Toshio Kojima, Aya Kitamoto, Yukihiro Akao, Yoshinori Nozawa, Masafumi Ito · 2012 · Neurochemistry International
  82. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats
    S. Ando, Tomoko Tadenuma, Yayoi Tanaka, Fumiko Fukui, Satoru Kobayashi, Yasushi Ohashi, T. Kawabata · 2001 · Journal of Neuroscience Research
  83. 8-Hydroxydihydrochelerythrine and 8-Hydroxydihydrosanguinarine with a Potent Acetylcholinesterase Inhibitory Activity from Chelidonium majus L.
    Kyung‐Mi Cho, Ick‐Dong Yoo, Won‐Gon Kim · 2006 · Biological and Pharmaceutical Bulletin
  84. In vitro acetylcholinesterase inhibitory activity and the antioxidant properties of Aegle marmelos leaf extract: implications for the treatment of Alzheimer's disease
    Md. Asaduzzaman, Md. Josim Uddin, M.A. Kader, AHM Khurshid Alam, Aziz Abdur Rahman, Mamunur Rashid, Kiyoko Kato, Toshihisa Tanaka, Masatoshi Takeda, Golam Sadik · 2014 · Psychogeriatrics
  85. The Emerging Therapeutic Role of NGF in Alzheimer’s Disease
    Chao‐Jin Xu, Jun‐Ling Wang, Weilin Jin · 2016 · Neurochemical Research
  86. Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells
    Yao Fei Hu, Zhuang-Yin Qu, Shi-Ying Cao, Qi Li, Lixiang Ma, Robert Krencik, Min Xu, Yan Liu · 2016 · Journal of Neuroscience Methods
  87. Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats
    Marco Giorgetti, Lucia Bacciottini, Maria Grazia Giovannini, Maria Alessandra Colivicchi, Joseph Goldfarb, Patrizio Blandina · 2000 · European Journal of Neuroscience
  88. Hippocampal choline acetyltransferase activity correlates with spatial learning in aged rats
    Gary Leo Dunbar, Rebecca Jane Rylett, Bonnie M. Schmidt · 1993 · Brain Research
  89. Candidates for cognitive enhancer extracted from medicinal plants: paeoniflorin and tetramethylpyrazine
    Hiroshi Watanabe · 1997 · Behavioural Brain Research
  90. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces
    Montford F. Piercey, Glenn D. Vogelsang, Stanley R. Franklin, Andy H. Tang · 1987 · Brain Research
  91. Aberrant phosphorylation of neurofilaments accompanies transmitter-related changes in rat septal neurons following transection of the fimbria-fornix
    Vassilis E. Koliatsos, Michael D. Applegate, Cheryl A. Kitt, Lary C. Walker, Mahlon R. DeLong, Donald L. Price · 1989 · Brain Research
  92. Ultrastructural organization of choline acetyltransferase‐immunoreactive fibres innervating the neocortex from embryonic ventral forebrain grafts
    Deborah J. Clarke, Stephen B. Dunnett · 1986 · The Journal of Comparative Neurology
  93. Improvement of 8-arm maze performance in aged fischer 344 rats with 3,4-diaminopyridine
    Hasker P. Davis, Augusta Idowu, Gary E. Gibson · 1983 · Experimental Aging Research
  94. Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation
    Maryam Moosavi, Golnaz Yadollahikhales, Leila Abbasi, Asadollah Zarifkar, Karim Rastegar · 2012 · Neuropharmacology
  95. Forebrain Deletion of the Vesicular Acetylcholine Transporter Results in Deficits in Executive Function, Metabolic, and RNA Splicing Abnormalities in the Prefrontal Cortex
    Benjamin Kolisnyk, Mohammed Al‐Onaizi, Pedro H. F. Hirata, Mónica S. Guzmán, Simona Nikolova, Shahar Barbash, Hermona Soreq, Robert Bartha, Marco A. M. Prado, Vânia F. Prado · 2013 · Journal of Neuroscience
  96. Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research
    Martin Engel, Dzung Do‐Ha, Sonia Sanz Muñoz, Lezanne Ooi · 2016 · Cellular and Molecular Life Sciences
  97. Interactions Between Phasic Alerting and Spatial Orienting: Effects of Normal Aging and Alzheimer's Disease.
    Elena K. Festa, Brian R. Ott, William C. Heindel · 2004 · Neuropsychology
  98. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert
    C Weis, Josef Marksteiner, Christian Humpel · 2001 · Neuroscience
  99. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer’s disease
    Aucoin, J.-S., Jiang, P., Aznavour, N., Tong, X.-K., Buttini, M., Descarries, L., Hamel, E. · 2005 · Neuroscience
  100. Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
    Dwomoh, Louis, Tejeda, Gonzalo S., Tobin, Andrew B. · 2022 · Neuronal Signaling